| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0026 | 1 |